Publicaciones (21) Publicaciones de RICARDO SAINZ DE LA CUESTA ABBAD

2023

  1. Targeting carcinoma-associated mesothelial cells with antibody–drug conjugates in ovarian carcinomatosis

    Journal of Pathology, Vol. 261, Núm. 2, pp. 238-251

2021

  1. Cellular integrin α5β1 and exosomal adam17 mediate the binding and uptake of exosomes produced by colorectal carcinoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  2. MRI guided ROLL/SNOLL in breast cancer patients treated with neoadjuvant chemotherapy

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 40, Núm. 2, pp. 91-99

  3. Mesothelial‐to‐mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  4. Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis

    Frontiers in Cell and Developmental Biology, Vol. 9

2020

  1. Patterns of relapse and pathological response according to surrogate type in breast cancer patients treated with neoadjuvant chemotherapy and negative axillary involvement

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 48, Núm. 4

2019

  1. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging

    Journal of Obstetrics and Gynaecology, Vol. 39, Núm. 1, pp. 98-104

2017

  1. Sonographic Evaluation of Fetal Adrenal Gland in Gestational Diabetes:: Relation to Fetal Growth and Maternal Biochemical Markers

    Journal of Ultrasound in Medicine, Vol. 36, Núm. 5, pp. 999-1007

2016

  1. Primary breast angiosarcoma in a young woman

    International Journal of Surgery Case Reports, Vol. 24, pp. 101-103

  2. Weight-related and analytical maternal factors in gestational diabetes to predict birth weight and cord markers of diabetic fetopathy

    Gynecological Endocrinology, Vol. 32, Núm. 7, pp. 548-552

2015

  1. Asymptomatic peritoneal carcinomatosis originating from benign cystic peritoneal mesothelioma

    ecancermedicalscience, Vol. 9

  2. Fetal limb soft tissue assessment for prediction of birth weight and umbilical cord blood analytes in gestational diabetes

    Prenatal Diagnosis, Vol. 35, Núm. 12, pp. 1187-1196

2013

  1. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma

    European Radiology, Vol. 23, Núm. 9, pp. 2636-2642

  2. Fetal magnetic resonance imaging and neurosonography in congenital neurological anomalies: Supplementary diagnostic and postnatal prognostic value

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Núm. 15, pp. 1517-1523

2006

  1. Mujeres con riesgo de desarrollar neoplasias malignas en la posmenopausia

    Medicina Clinica Monografias, Vol. 7, Núm. 3, pp. 31-38

2004

  1. Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? a randomized controlled trial

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 115, Núm. 2, pp. 211-215

  2. Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 113, Núm. 1, pp. 87-93

1998

  1. Evaluation of non-invasive diagnostic tests for the second look in epithelial ovarian cancer

    Revista Clinica Espanola, Vol. 198, Núm. 8, pp. 502-505

1996

  1. Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

    Gynecologic Oncology, Vol. 60, Núm. 3, pp. 412-417

  2. Histologic transformation of benign endometriosis to early epithelial ovarian cancer

    Gynecologic Oncology, Vol. 60, Núm. 2, pp. 238-244